A detailed history of Old National Bancorp transactions in Takeda Pharmaceutical CO LTD stock. As of the latest transaction made, Old National Bancorp holds 31,261 shares of TAK stock, worth $462,975. This represents 0.01% of its overall portfolio holdings.

Number of Shares
31,261
Previous 28,964 7.93%
Holding current value
$462,975
Previous $402,000 0.5%
% of portfolio
0.01%
Previous 0.01%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 11, 2024

BUY
$12.6 - $13.67 $28,942 - $31,399
2,297 Added 7.93%
31,261 $404,000
Q1 2024

Apr 15, 2024

BUY
$13.89 - $15.04 $28,238 - $30,576
2,033 Added 7.55%
28,964 $402,000
Q4 2023

Feb 01, 2024

SELL
$13.36 - $15.43 $17,942 - $20,722
-1,343 Reduced 4.75%
26,931 $384,000
Q3 2023

Nov 17, 2023

BUY
$15.03 - $16.32 $4,373 - $4,749
291 Added 1.04%
28,274 $437,000
Q2 2023

Jul 25, 2023

BUY
$15.57 - $17.11 $105,611 - $116,057
6,783 Added 32.0%
27,983 $439,000
Q1 2023

Apr 19, 2023

BUY
$15.28 - $16.48 $28,634 - $30,883
1,874 Added 9.7%
21,200 $349,000
Q4 2022

Feb 03, 2023

SELL
$12.42 - $15.62 $6,321 - $7,950
-509 Reduced 2.57%
19,326 $301,000
Q3 2022

Feb 17, 2023

BUY
$12.8 - $28.65 $6,515 - $14,582
509 Added 2.63%
19,835 $257,000
Q3 2022

Nov 08, 2022

BUY
$12.8 - $28.65 $95,744 - $214,302
7,480 Added 60.54%
19,835 $257,000
Q2 2022

Jul 25, 2022

BUY
$13.12 - $15.03 $6,914 - $7,920
527 Added 4.46%
12,355 $173,000
Q1 2022

May 09, 2022

SELL
$13.54 - $15.35 $704 - $798
-52 Reduced 0.44%
11,828 $169,000
Q4 2021

Jan 25, 2022

SELL
$13.17 - $16.4 $6,150 - $7,658
-467 Reduced 3.78%
11,880 $162,000
Q2 2021

Jul 26, 2021

BUY
$16.55 - $18.64 $204,342 - $230,148
12,347 New
12,347 $208,000

Others Institutions Holding TAK

About TAKEDA PHARMACEUTICAL CO LTD


  • Ticker TAK
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 3,109,050,112
  • Market Cap $46B
  • Description
  • Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...
More about TAK
Track This Portfolio

Track Old National Bancorp Portfolio

Follow Old National Bancorp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Old National Bancorp , based on Form 13F filings with the SEC.

News

Stay updated on Old National Bancorp with notifications on news.